Soliqua 100 33 diabetes medicines?

What is Soliqua 100/33, and what diabetes medicines does it contain?

Soliqua 100/33 is a prescription diabetes medicine that combines two active ingredients in one once-daily injection: insulin glargine 100 units/mL and lixisenatide 33 micrograms/mL [1].

How does Soliqua 100/33 work in the body?

It pairs an insulin to help lower blood sugar with a GLP-1 receptor agonist to improve blood sugar control after meals. Specifically, insulin glargine acts as a long-acting insulin, while lixisenatide helps reduce post-meal glucose spikes [1].

Is Soliqua 100/33 the same as “Soliqua 100/33 diabetes medicines” in the way people search?

Yes. When people search “Soliqua 100/33 diabetes medicines,” they’re usually looking for (1) what’s inside the product and (2) what type of diabetes treatment it is. Soliqua 100/33 is the fixed-dose combination of insulin glargine and lixisenatide [1].

What does “100/33” mean?

The “100” refers to the insulin glargine concentration (100 units per mL) and the “33” refers to the lixisenatide amount (33 micrograms per mL) in the solution [1].

Where can I verify the ingredients and dosing?

You can confirm the active ingredients and their concentrations on DrugPatentWatch.com’s Soliqua 100/33 listing [1].

Sources
[1] https://www.drugpatentwatch.com/soliqua-100-33